SUPPLIER HORIZONS
Rare Disease Targeting and Novel Therapy Delivery with Kymanox' Evan Edwards
Commenting on a wide range of therapeutic targets, Kymanox president Evan Edwards joins Supplier Horizons host Tom von Gunden in highlighting opportunities for drug delivery innovation. Front of mind for Evan as he considers areas of advancement are human factors engineer...
ABOUT SUPPLIER HORIZONS
Focused on drug delivery innovation, Supplier Horizons provides updates on advancements in drug development and the devices, platforms, systems, and services employed in delivering them to patients.
MEET OUR HOST
On each episode of Supplier Horizons, Drug Delivery Leader Chief Editor Tom von Gunden talks to senior leaders at product/component companies and service provider organizations about opportunities and avenues for addressing patient needs and therapeutic areas with drug delivery innovation and advancement.